PharmaCyte Biotech, Inc. Contracts & Agreements

102 Contracts & Agreements
Browse by Contract Category
Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Description of PharmaCyte Biotech, Inc. Securities Registered Under Section 12 of the Exchange Act
Equity Distribution Agreements
PharmaCyte Biotech, Inc.
Biotechnology
2024
Securities Purchase Agreement between MyMD Pharmaceuticals, Inc. and PharmaCyte Biotech, Inc. dated May 20, 2024
Purchase Agreements
PharmaCyte Biotech, Inc.
Biotechnology
DE
2024
Certificate of Designations of Series G Convertible Preferred Stock of MyMD Pharmaceuticals, Inc.
Articles of Amendment
PharmaCyte Biotech, Inc.
Biotechnology
NY
2024
Warrant Agreement to Purchase Common Stock between MyMD Pharmaceuticals, Inc. and Holder
Warrant Agreements
PharmaCyte Biotech, Inc.
Biotechnology
NY
2024
Short-Term Warrant to Purchase Common Stock Agreement between MyMD Pharmaceuticals, Inc. and Holder
Warrant Agreements
PharmaCyte Biotech, Inc.
Biotechnology
NY
2024
Registration Rights Agreement between MyMD Pharmaceuticals, Inc. and Pharmacyte Biotech, Inc. dated May 20, 2024
Registration Rights Agreements
PharmaCyte Biotech, Inc.
Biotechnology
NY
2024
Series A Warrant to Purchase Common Stock between Femasys Inc. and PharmaCyte Biotech, Inc.
Warrant Agreements
PharmaCyte Biotech, Inc.
Biotechnology
NY
2023
Series B Warrant to Purchase Common Stock between Femasys Inc. and PharmaCyte Biotech, Inc.
Warrant Agreements
PharmaCyte Biotech, Inc.
Biotechnology
NY
2023
Securities Purchase Agreement between Femasys Inc. and Investors (November 2023)
Purchase Agreements
PharmaCyte Biotech, Inc.
Biotechnology
NY
2023
Senior Unsecured Convertible Note between Femasys Inc. and PharmaCyte Biotech, Inc.
Note Agreements
PharmaCyte Biotech, Inc.
Biotechnology
NY
2023
Registration Rights Agreement between Femasys Inc. and Buyers (November 14, 2023)
Registration Rights Agreements
PharmaCyte Biotech, Inc.
Biotechnology
NY
2023
Collaboration Agreement between PharmaCyte Biotech, Inc. and Femasys Inc.
Collaboration Agreements
PharmaCyte Biotech, Inc.
Biotechnology
NY
2023
PharmaCyte Biotech, Inc. Warrant to Purchase Common Stock Agreement (May 2023)
Warrant Agreements
PharmaCyte Biotech, Inc.
Biotechnology
NY
2023
Securities Purchase Agreement between PharmaCyte Biotech, Inc. and Investors (May 2023)
Purchase Agreements
PharmaCyte Biotech, Inc.
Biotechnology
NY
2023
Registration Rights Agreement between PharmaCyte Biotech, Inc. and Buyers (May 9, 2023)
Registration Rights Agreements
PharmaCyte Biotech, Inc.
Biotechnology
NY
2023
Placement Agent Agreement between Pharmacyte Biotech, Inc. and Katalyst Securities LLC for Private Placement of Series B Convertible Preferred Stock and Warrants
PharmaCyte Biotech, Inc.
Biotechnology
NY
2023
Release Agreement between PharmaCyte Biotech, Inc. and Gerald W. Crabtree
Release Agreements
PharmaCyte Biotech, Inc.
Biotechnology
2022
Separation, Consulting and Release Agreement between PharmaCyte Biotech, Inc. and Kenneth L. Waggoner
Separation Agreements
PharmaCyte Biotech, Inc.
Biotechnology
NV
2022
Cooperation Agreement between PharmaCyte Biotech, Inc. and Iroquois Master Fund Ltd. (August 2022)
Cooperation Agreements
PharmaCyte Biotech, Inc.
Biotechnology
NV
2022
PharmaCyte Biotech, Inc. Director Offer Letter Agreement
Consulting Agreements
PharmaCyte Biotech, Inc.
Biotechnology
NV
2022
Description of PharmaCyte Biotech, Inc. Common Stock Registered Under Section 12 of the Exchange Act
Equity Distribution Agreements
PharmaCyte Biotech, Inc.
Biotechnology
2022
Amended and Restated Executive Compensation Agreement between PharmaCyte Biotech, Inc. and Kenneth L. Waggoner (May 8, 2022)
Compensation Agreements
PharmaCyte Biotech, Inc.
Biotechnology
NV
2022
Amended and Restated Executive Compensation Agreement between PharmaCyte Biotech, Inc. and Carlos A. Trujillo (May 8, 2022)
Compensation Agreements
PharmaCyte Biotech, Inc.
Biotechnology
NV
2022
PharmaCyte Biotech, Inc. 2021 Equity Incentive Plan
Bonus & Incentive Agreements
PharmaCyte Biotech, Inc.
Biotechnology
NV
2022
Pre-Funded Common Stock Purchase Warrant Agreement between PharmaCyte Biotech, Inc. and Holder (August 23, 2021)
Warrant Agreements
PharmaCyte Biotech, Inc.
Biotechnology
NY
2021
PharmaCyte Biotech, Inc. Series A Common Stock Purchase Warrant Agreement
Warrant Agreements
PharmaCyte Biotech, Inc.
Biotechnology
NY
2021
PharmaCyte Biotech, Inc. Placement Agent Common Stock Purchase Warrant Agreement with H.C. Wainwright & Co., LLC
Warrant Agreements
PharmaCyte Biotech, Inc.
Biotechnology
NY
2021
Securities Purchase Agreement between PharmaCyte Biotech, Inc. and Purchasers dated August 19, 2021
Purchase Agreements
PharmaCyte Biotech, Inc.
Biotechnology
NY
2021
Underwriting Agreement between PharmaCyte Biotech, Inc. and H.C. Wainwright & Co., LLC, dated August 9, 2021
Underwriting Agreements
PharmaCyte Biotech, Inc.
Biotechnology
NY
2021
Common Stock Purchase Warrant Agreement between PharmaCyte Biotech, Inc. and Holder
Warrant Agreements
PharmaCyte Biotech, Inc.
Biotechnology
NY
2021
Pre-Funded Common Stock Purchase Warrant Agreement between PharmaCyte Biotech, Inc. and Holder
Warrant Agreements
PharmaCyte Biotech, Inc.
Biotechnology
NY
2021
Underwriter Common Stock Purchase Warrant between PharmaCyte Biotech, Inc. and H.C. Wainwright & Co., LLC
Warrant Agreements
PharmaCyte Biotech, Inc.
Biotechnology
NY
2021
Description of PharmaCyte Biotech, Inc. Common Stock Registered Under Section 12 of the Exchange Act
Equity Distribution Agreements
PharmaCyte Biotech, Inc.
Biotechnology
2021
Amendment No. 3 to Executive Compensation Agreement between PharmaCyte Biotech, Inc. and Gerald W. Crabtree
Compensation Agreements
PharmaCyte Biotech, Inc.
Biotechnology
2020
Right of First Refusal Agreement between PharmaCyte Biotech, Inc. and Silver Rock Associates, Inc.
Purchase Agreements
PharmaCyte Biotech, Inc.
Biotechnology
2020
Amendment No. 1 to Right of First Refusal Agreement between PharmaCyte Biotech, Inc. and Silver Rock Associates, Inc.
Modification Agreements
PharmaCyte Biotech, Inc.
Biotechnology
CA
2020
Share Subscription Agreement between PharmaCyte Biotech, Inc. and Subscriber for 30,000,000 Shares
Subscription Agreements
PharmaCyte Biotech, Inc.
Biotechnology
NV
2020
Fourth Addendum to Asset Purchase Agreement between PharmaCyte Biotech, Inc. and SG Austria Pte. Ltd.
Purchase Agreements
PharmaCyte Biotech, Inc.
Biotechnology
2018
Third Amendment to Licensing Agreement between PharmaCyte Biotech, Inc. and Austrianova Singapore Pte Ltd
License Agreements
PharmaCyte Biotech, Inc.
Biotechnology
2018
Second Amendment to Licensing Agreement between PharmaCyte Biotech, Inc. and Austrianova Singapore Pte. Ltd.
License Agreements
PharmaCyte Biotech, Inc.
Biotechnology
2018
Engagement Letter Between PharmaCyte Biotech, Inc. and Aeon Capital, Inc. for Financial Advisory and At-the-Market Offering Services
Equity Distribution Agreements
PharmaCyte Biotech, Inc.
Biotechnology
2018
Mutual Termination Agreement between PharmaCyte Biotech, Inc. and Chardan Capital Markets, LLC
Termination Agreements
PharmaCyte Biotech, Inc.
Biotechnology
2018
Director Letter Agreement between PharmaCyte Biotech, Inc. and Dr. Raymond C.F. Tong (October 9, 2017)
Consulting Agreements
PharmaCyte Biotech, Inc.
Biotechnology
CA
2017
Binding Term Sheet Among Austrianova Singapore, SG Austria, and PharmaCyte Biotech Regarding Amendments to License and Asset Purchase Agreements
Term Sheets
PharmaCyte Biotech, Inc.
Biotechnology
2017
Director Offer Letter Agreement between PharmaCyte Biotech and Michael Abecassis, M.D.
Employment Agreements
PharmaCyte Biotech, Inc.
Biotechnology
CA
2017
Director Offer Letter Agreement between PharmaCyte Biotech and Thomas C. K. Yuen
Employment Agreements
PharmaCyte Biotech, Inc.
Biotechnology
CA
2017
Amendment No. 2 to Executive Compensation Agreement between PharmaCyte Biotech, Inc. and Kenneth L. Waggoner
Compensation Agreements
PharmaCyte Biotech, Inc.
Biotechnology
NV
2017
Amendment No. 2 to Executive Compensation Agreement between PharmaCyte Biotech, Inc. and Carlos A. Trujillo
Compensation Agreements
PharmaCyte Biotech, Inc.
Biotechnology
NV
2017
Amendment No. 2 to Executive Compensation Agreement between PharmaCyte Biotech, Inc. and Gerald W. Crabtree
Employment Agreements
PharmaCyte Biotech, Inc.
Biotechnology
NV
2017
Fourth Stock Option Agreement between PharmaCyte Biotech, Inc. and Kenneth L. Waggoner
Warrant Agreements
PharmaCyte Biotech, Inc.
Biotechnology
NV
2017
Third Stock Option Agreement between PharmaCyte Biotech, Inc. and Carlos A. Trujillo
Warrant Agreements
PharmaCyte Biotech, Inc.
Biotechnology
NV
2017
Fourth Stock Option Agreement between PharmaCyte Biotech, Inc. and Gerald W. Crabtree
Stock Agreements
PharmaCyte Biotech, Inc.
Biotechnology
NV
2017
Amendment No. 1 to Director Offer Letter between PharmaCyte Biotech, Inc. and Thomas Liquard
Modification Agreements
PharmaCyte Biotech, Inc.
Biotechnology
2017
Amendment to Engagement Letter between PharmaCyte Biotech, Inc. and Chardan Capital Markets, LLC (December 15, 2016)
Advisory Agreements
PharmaCyte Biotech, Inc.
Biotechnology
2016
Second Amendment to License Agreement between Bavarian Nordic A/S, Helmholtz Zentrum München/GSF, and Bio Blue Bird AG
License Agreements
PharmaCyte Biotech, Inc.
Biotechnology
2016
First Amendment to Licensing Agreement between PharmaCyte Biotech, Inc. and Austrianova Singapore Pte Ltd
License Agreements
PharmaCyte Biotech, Inc.
Biotechnology
2016
Second Amendment to Licensing Agreement between PharmaCyte Biotech, Inc. and Austrianova Singapore Pte Ltd
License Agreements
PharmaCyte Biotech, Inc.
Biotechnology
2016
Variation to License Agreement between University of Technology, Sydney and Pharmacyte Biotech Australia Pty Ltd (April 20, 2016)
License Agreements
PharmaCyte Biotech, Inc.
Biotechnology
2016
First Amendment to Licensing Agreement between PharmaCyte Biotech, Inc. and Austrianova Singapore Pte Ltd
License Agreements
PharmaCyte Biotech, Inc.
Biotechnology
2016
Binding Memorandum of Understanding Between PharmaCyte Biotech, Inc. and Austrianova Singapore Pte Ltd (July 28, 2016)
MOUs
PharmaCyte Biotech, Inc.
Biotechnology
2016
Amendment No. 1 to Executive Compensation Agreement between PharmaCyte Biotech, Inc. and Gerald W. Crabtree
Compensation Agreements
PharmaCyte Biotech, Inc.
Biotechnology
2016
Amendment No. 1 to Executive Compensation Agreement between PharmaCyte Biotech, Inc. and Kenneth L. Waggoner
Compensation Agreements
PharmaCyte Biotech, Inc.
Biotechnology
2016
PharmaCyte Biotech, Inc. Third Stock Option Agreement with Gerald W. Crabtree (December 30, 2015)
Warrant Agreements
PharmaCyte Biotech, Inc.
Biotechnology
NV
2016
PharmaCyte Biotech, Inc. Third Stock Option Agreement with Kenneth L. Waggoner (2015)
Warrant Agreements
PharmaCyte Biotech, Inc.
Biotechnology
NV
2016
Common Stock Warrant Agreement between PharmaCyte Biotech, Inc. and Berkshire Capital Management Co., Inc.
Warrant Agreements
PharmaCyte Biotech, Inc.
Biotechnology
2016
Common Stock Warrant Agreement between PharmaCyte Biotech, Inc. and SPYR, Inc. dated January 7, 2016
Warrant Agreements
PharmaCyte Biotech, Inc.
Biotechnology
2016
Stock and Warrant Purchase Agreement between PharmaCyte Biotech, Inc. and Berkshire Capital Management Co., Inc.
Stock Agreements
PharmaCyte Biotech, Inc.
Biotechnology
NV
2016
Stock and Warrant Purchase Agreement between PharmaCyte Biotech, Inc. and SPYR, Inc. dated January 7, 2016
Purchase Agreements
PharmaCyte Biotech, Inc.
Biotechnology
NV
2016
PharmaCyte Biotech Director Offer Letter Agreement with Thomas Liquard (April 2015)
Employment Agreements
PharmaCyte Biotech, Inc.
Biotechnology
MD
2015
Executive Compensation Agreement between PharmaCyte Biotech, Inc. and Kenneth L. Waggoner dated March 10, 2015
Compensation Agreements
PharmaCyte Biotech, Inc.
Biotechnology
MD
2015
PharmaCyte Biotech, Inc. Stock Option Agreement with Kenneth L. Waggoner (March 10, 2015)
Warrant Agreements
PharmaCyte Biotech, Inc.
Biotechnology
NV
2015
Second Stock Option Agreement between PharmaCyte Biotech, Inc. and Kenneth L. Waggoner (March 10, 2015)
Warrant Agreements
PharmaCyte Biotech, Inc.
Biotechnology
NV
2015
Executive Compensation Agreement between PharmaCyte Biotech, Inc. and Gerald W. Crabtree
Compensation Agreements
PharmaCyte Biotech, Inc.
Biotechnology
MD
2015
PharmaCyte Biotech, Inc. First Stock Option Agreement with Gerald W. Crabtree
Warrant Agreements
PharmaCyte Biotech, Inc.
Biotechnology
NV
2015
Second Stock Option Agreement between PharmaCyte Biotech, Inc. and Gerald W. Crabtree (March 10, 2015)
Warrant Agreements
PharmaCyte Biotech, Inc.
Biotechnology
NV
2015
Exclusive Worldwide License Agreement between Austrianova Singapore Pte Ltd and Nuvilex Inc. for Cell-in-a-Box® Technology in Cannabinoid Therapies
License Agreements
PharmaCyte Biotech, Inc.
Biotechnology
2014
Consulting Agreement between Nuvilex, Inc. and Patricia Gruden (October 1, 2014)
Consulting Agreements
PharmaCyte Biotech, Inc.
Biotechnology
MD
2014
Nuvilex, Inc. and Patricia Gruden Stock Option Agreement dated September 29, 2014
Warrant Agreements
PharmaCyte Biotech, Inc.
Biotechnology
NY
2014
Consulting Agreement between Nuvilex, Inc. and Timothy Matula (Effective October 1, 2014)
Consulting Agreements
PharmaCyte Biotech, Inc.
Biotechnology
MD
2014
Nuvilex, Inc. Stock Option Agreement with Timothy Matula (September 29, 2014)
Warrant Agreements
PharmaCyte Biotech, Inc.
Biotechnology
NY
2014
Consulting Agreement between Nuvilex, Inc. and Richard M. Goldfarb
Consulting Agreements
PharmaCyte Biotech, Inc.
Biotechnology
MD
2014
Stock Option Agreement between Nuvilex, Inc. and Richard M. Goldfarb (September 29, 2014)
Warrant Agreements
PharmaCyte Biotech, Inc.
Biotechnology
NY
2014
Settlement Agreement between Nuvilex, Inc. and Robert F. Ryan, M.S., Ph.D.
Settlement Agreements
PharmaCyte Biotech, Inc.
Biotechnology
MD
2014
Asset Purchase Agreement between Nuvilex, Inc. and Robert F. Ryan, M.S., Ph.D.
Purchase Agreements
PharmaCyte Biotech, Inc.
Biotechnology
MD
2014
License Agreement for Encapsulated Cell Technology Between Bavarian Nordic A/S, GSF, and Bio Blue Bird AG
License Agreements
PharmaCyte Biotech, Inc.
Biotechnology
2014
Amendment to License Agreement Between Bavarian Nordic A/S, GSF, and Bio Blue Bird AG (December 20, 2006)
License Agreements
PharmaCyte Biotech, Inc.
Biotechnology
2014
Manufacturing Framework Agreement between Austrianova Singapore Pte. Ltd. and Nuvilex, Inc.
Supply Agreements
PharmaCyte Biotech, Inc.
Biotechnology
2014
Master Services Agreement between ViruSure GmbH and Nuvilex, Inc. dated April 7, 2014
Services Agreements
PharmaCyte Biotech, Inc.
Biotechnology
2014
Consulting Agreement between Nuvilex, Inc. and Vin-de-Bona Trading Company Pte Ltd (April 1, 2014)
Consulting Agreements
PharmaCyte Biotech, Inc.
Biotechnology
2014
Master Consultancy Agreement between Nuvilex, Inc. and BB Biotech Consulting GmbH
Consulting Agreements
PharmaCyte Biotech, Inc.
Biotechnology
2014
Memorandum of Understanding Regarding Compensation Between Nuvilex, Inc. and Dr. Robert F. Ryan
MOUs
PharmaCyte Biotech, Inc.
Biotechnology
2014
Employment Agreement between Nuvilex, Inc. and Dr. Robert F. Ryan (President, CEO, Interim CFO)
Employment Agreements
PharmaCyte Biotech, Inc.
Biotechnology
NV
2014
Purchase Agreement between Nuvilex, Inc. and Lincoln Park Capital Fund, LLC (February 14, 2014)
Purchase Agreements
PharmaCyte Biotech, Inc.
Biotechnology
NY
2014
Third Addendum to Asset Purchase Agreement between Nuvilex, Inc. and SG Austria Private Limited (June 25, 2013)
Purchase Agreements
PharmaCyte Biotech, Inc.
Biotechnology
2013
Exclusive Licensing Agreement between Austrianova Singapore Pte Ltd. and Nuvilex Inc. for Cell-in-a-Box® Technology in Diabetes Treatment
License Agreements
PharmaCyte Biotech, Inc.
Biotechnology
2013
Real Estate Sale Agreement between Freedom2, Inc. and Kol Marble and Granite (February 16, 2010)
Purchase Agreements
PharmaCyte Biotech, Inc.
Biotechnology
2010
Scott McFee Resignation Letter as Director of e-FoodSafety.com, Inc.
Separation Agreements
PharmaCyte Biotech, Inc.
Biotechnology
2004
Ralph Baughman Resignation Letter from eFoodSafety.com, Inc. Board of Directors
Separation Agreements
PharmaCyte Biotech, Inc.
Biotechnology
2004
Mutual Termination and Release Agreement between Nuvilex, Inc. and Lincoln Park Capital Fund, LLC (May 28, 2014)
Release Agreements
PharmaCyte Biotech, Inc.
Biotechnology
NY
2014
Financial Advisory and At-the-Market Offering Engagement Letter between Nuvilex, Inc. and Chardan Capital Markets, LLC
Equity Distribution Agreements
PharmaCyte Biotech, Inc.
Biotechnology
2014
Letter Agreement Extending Registration Statement Filing Deadline between Nuvilex, Inc. and Lincoln Park Capital Fund, LLC
Modification Agreements
PharmaCyte Biotech, Inc.
Biotechnology
2014
Registration Rights Agreement between Nuvilex, Inc. and Lincoln Park Capital Fund, LLC
Registration Rights Agreements
PharmaCyte Biotech, Inc.
Biotechnology
NY
2014